Slingshot members are tracking this event:
FDA Decision on Supplemental Application for Portola's (PTLA) Andexxa (Andexanet Alfa) Expected in May 4 2018
Slingshot Insights Explained
May 03, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Supplemental Application, Fda, Andexxa, Andexanet Alfa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery